A pathogenic role of visceral fat β3-adrenoceptors in obesity

Journal of Clinical Investigation

Volumn 95, Issue 3, 1995, Pages 1109-1116

  Lönnqvist, Fredrik ^b   Thörne, Anders ^a   Nilsell, Klas ^a   Hoffstedt, Johan ^b   Arner, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; BRIMONIDINE; CHOLESTEROL; DOBUTAMINE; FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; ISOPRENALINE; NORADRENALIN; RECEPTOR SUBTYPE; TERBUTALINE; TRIACYLGLYCEROL;

ADIPOCYTE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLYCEROL BLOOD LEVEL; HEMODYNAMIC MONITORING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID METABOLISM; MALE; OBESITY; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0028912885     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117758     Document Type: Article

References (43)

1. Kaplan, N. M. 1989. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 149:1514-1520.
2. Björntorp, P. 1991. Metabolic implications of body fat distribution. Diabetes Care. 14:1132-1143.
3. Frayn, K. N., and S. W. Coppack. 1992. Insulin resistance, adipose tissue and coronary heart disease. Clin. Sci. (Lond.). 82:1-8.
4. Sjöström, L. 1991. A computer-tomography based multicompartment body composition technique and anthropometric predictions of lean body mass, total and subcutaneous adipose tissue. Int. J. Obes. 15:19-30.
5. Ferranini, E., E. J. Barrett, S. Bevilaquas, and R. A. DeFronzo. 1983. Effects of fatty acid on glucose production and utilization in man. J. Clin. Invest. 72:1737-1744.
6. Felber, M. G., and R. Jequier. 1982. Glucose storage deficiency as a cause of insulin resistance in obese hyperinsulinaemic diabetes. Int. J. Obes. 6(Suppl. 1):131-135.
7. Jensen, M. D., M. W. Haymond, R. A. Rizza, P. E. Cryer, and J. M. Miles. 1989. Influence of body fat distribution on free fatty acid metabolism in obesity. J. Clin. Invest. 83:1168-1173.
8. Jensen, M. D. 1991. Regulation of forearm lipolysis in different types of obesity. J. Clin. Invest. 87:187-193.
9. Martin, M. L., and M. D. Jensen. 1991. Effects of body fat distribution on regional lipolysis in obesity. J. Clin. Invest. 88:609-613.
10. Arner, P. 1992. Adrenergic receptor function in fat cells. Am. J. Clin. Nutr. 55:228S-236S.
11. Lafontan, M., and M. Berlan. 1993. Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid Res. 34:1057-1092.
12. 3-adrenergic receptor. Science (Wash. DC). 245:1118-1121.
13. 3 and atypical β-adrenoceptors. Med. Res. Rev. 13:663-729.
14. 3-adrenergic receptor mRNA in man. J. Clin. Invest. 91:344-349.
15. Langin, D., M. Portillo, J. S. Saulnier-Blanche, and M. Lafontan. 1991. Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol. 199:291-301.
16. 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. J. Clin. Endocrinol. & Metab. 77:352-355.
17. Hollenga, C., M. Haas, J. T. Deinum, and J. Zaagsma. 1990. Discrepancies in lipolytic activities induced by β-adrenoceptor agonists in human and rat adipocytes. Horm. Metab. Res. 22:17-21.
18. 3-adrenergic receptor in man. Br. J. Pharmacol. 110:929-936.
19. Kenakin, T. 1984. The classification of drugs and drug receptors in isolated tissue. Pharmacological Reviews. 36:165-214.
20. Rodbell, M. 1964. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 239:375-380.
21. Di Girolamo, M., S. Mendlinger, and J. W. Fertig. 1971. A simple method to determine fat cell size and number in four mammalian species. Am. J. Physiol. 221:850-858.
22. Hirsch, J., and E. Gallian. 1968. Methods for determination of adipose cell size and number in man and animals. J. Lipid Res. 9:110-119.
23. Kather, H., E. Wieland, A. Scheurer, G. Vogel, U. Widenberg, and C. Joose. 1987. Influences of variation in total energy intake and dietary composition. J. Clin. Invest. 80:566-572.
24. Arner, P., J. Bolinder, J. Hellmér, and P. Engfeldt. 1986. Studies on human fat cell metabolism in small adipose tissue samples. In Methods in Diabetes Research. Vol. 2. W. L. Clarke, J. Larner, and S. L. Pohl, editors. John Wiley and Sons Inc., New York. 234-258.
25. 2-agonist for the characterization of alpha-adrenoceptor subtypes. Eur. J. Pharmacol. 72:413-415.
26. Lönqvist, F., and P. Arner. 1989. Interaction beween adenylate cyclase inhibitors and beta-adrenoceptors in isolated human fat cells. Biochem. Biophys. Res. Commun. 161:654-660.
27. Marcus, C., B. Karpe, P. Bolme, T. Sonnenfeldt, and P. Arner. 1987. Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life. J. Clin. Invest. 79:1812-1818.
28. Lönqvist, F., A. Wennlund, and P. Arner. 1989. Antilipolytic effects of insulin and adenylate cyclase inhibitors on isolated human fat cells. Int. J. Obes. 13:137-146.
29. Hellmér, J., P. Arner, and A. Lundin. 1989. Automatic luminometric kinetic assay of glycerol for lipolysis studies. Anal. Biochem. 177:132-137.
30. Östman, J., P. Arner, H. Kimura, H. Wahrenberg, and P. Engfeldt. 1984. Influence of fasting on lipolytic response to adrenergic agonists and on adrenergic receptors in subcutaneous adipocytes. Eur. J. Clin. Invest. 13:383-391.
31. Näslund, B., K. Bernström, A. Lundin, and P. Arner. 1993. Release of small amounts of free fatty acids from human adipocytes as determined by chemiluminescence. J. Lipid Res. 34:633-642.
32. Wolfe, R. R., E. J. Peters, S. Klein, O. B. Holland, J. Rosenblatt, and H. Gary. 1987. Effect of short-term fasting on lipolytic responsiveness in normal and obese human subjects. Am. J. Physiol. 2523:E189-E196.
33. Connacher, A. A., W. M. Bennet, R. T. Jung, D. M. Bier, C. T. Smith, C. M. Scrimgeour, and M. J. Rennie. 1991. Effect of adrenaline infusion on fatty acid and glucose turnover in lean and obese human subjects in post-absorptive and fed states. Clin. Sci. (Lond.). 81:635-644.
34. Mauriege, P., J. P. Després, D. Prud'homme, M. C. Pouliot, M. Marcotte, A. Tremblay, and C. Bouchard. 1991. Regional variation in adipose tissue lipolysis in lean and obese men. J. Lipid Res. 32:1625-1633.
35. 2-adrenoceptors. Diabetologia. 37:428-435.
36. Roust, L. R., and M. D. Jensen. 1993. Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes. 42:1567-1573.
37. Basso, L. V., and R. J. Havel. 1970. Hepatic metabolism of free fatty acids in normal and diabetic dogs. J. Clin. Invest. 49:537-547.
38. 3-adrenergic receptor genes contain an intron within the protein coding block. Mol. Pharmacol. 42:964-970.
39. 3-adrenergic receptor balance in 3T3-F442A adipocytes. J. Biol. Chem. 269:6664-6670.
40. Muzzin, P., J. P. Revelli, F. Kuhne, J. D. Gocayne, W. R. Mccombie, J. C. Venter, J. P. Giacobino, and C. M. Fraser. 1991. An adipose tissue-specific β-adrenergic receptor. Molecular cloning and down-regulation in obesity. J. Biol. Chem. 266:24053-24058.
41. Taouis, M., P. Valet, L. Estan, M. Lafontan, P. Monastruc, and M. Berlan. 1989. Obesity modifies the adrenergic status of dog adipose tissue. J. Pharmacol. Exp. Ther. 250:1061-1066.
42. van der Kooy, K., and J. C. Seidell. 1993. Techniques for the measurement of visceral fat: a practical guide. Int. J. Obes. 17:187-196.
43. 3-adrenergic agonists. Drugs Future. 18:529-549.